GOLDMAN SACHS GROUP INC - CHEMBIO DIAGNOSTICS INC ownership

CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 23 filers reported holding CHEMBIO DIAGNOSTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CHEMBIO DIAGNOSTICS INC
ValueSharesWeighting
Q4 2021$105,000
-55.9%
92,168
+14.9%
0.00%
Q2 2021$238,000
+510.3%
80,184
+615.7%
0.00%
Q1 2021$39,000
-95.9%
11,203
-94.4%
0.00%
Q4 2020$950,000
+787.9%
200,047
+508.6%
0.00%
Q2 2020$107,000
-29.1%
32,871
+32.1%
0.00%
Q2 2017$151,000
+259.5%
24,881
+138.0%
0.00%
Q3 2015$42,000
-32.3%
10,456
-16.6%
0.00%
Q2 2015$62,000
+44.2%
12,534
+14.3%
0.00%
Q4 2014$43,00010,9650.00%
Other shareholders
CHEMBIO DIAGNOSTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,150,925$7,826,0002.91%
New Jersey Better Educational Savings Trust 158,000$1,074,0000.69%
ARS Investment Partners, LLC 620,936$4,222,0000.65%
PERKINS CAPITAL MANAGEMENT INC 68,050$463,0000.51%
First Light Asset Management, LLC 76,302$519,0000.23%
Kovack Advisors, Inc. 33,509$228,0000.11%
WHITE PINE CAPITAL LLC 32,625$222,0000.09%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 97,823$665,0000.06%
TAURUS ASSET MANAGEMENT, LLC 17,000$116,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 107,500$731,0000.01%
View complete list of CHEMBIO DIAGNOSTICS INC shareholders